Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 140.70M
December 31, 2025 283.93M
June 30, 2025 339.19M
December 31, 2024 274.05M
June 30, 2024 230.27M
December 31, 2023 228.57M
June 30, 2023 102.73M
December 31, 2022 144.23M
June 30, 2022 185.97M
December 31, 2021 213.77M
June 30, 2021 278.19M
Date Value
December 31, 2020 307.69M
June 30, 2020 301.08M
December 31, 2019 344.38M
June 30, 2019 321.15M
December 31, 2018 287.55M
June 30, 2018 264.23M
December 31, 2017 216.83M
June 30, 2017 66.70M
December 31, 2016 7.400M
June 30, 2016 72.21M
December 31, 2015 62.51M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Smith & Nephew plc 849.38M
Tristel Plc 12.32M
Abingdon Health Plc --
Creo Medical Group Plc -59.13M
Abbott Laboratories 7.824B

Free Cash Flow Related Metrics